USP Monographs Should Be Developed By Public/Private Partnership, Congress Says
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA is urged to seek adequate funding in the FY 2006 budget request to support the effort to increase the number of formal monographs for drug compounding, the report for the FY 2005 spending bill states. The bill provides FDA with $1.79 bil.